-
-
-
-
-
-
-
Bausch Health Co. Inc. (BHC) Tops Q2 EPS by 23c; updates guidance
-
-
-
-
-
-
-
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
-
-
-
-
-
-
-
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026
-
-
-
-
-
-
-
Bausch Health to Announce Third Quarter 2025 Results on October 29
-
-
-
-
-
-
-
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
-
-
-
-
-
-
-
Bausch Health Announces Third Quarter 2024 Results
-
-
-
-
-
-
-
Bausch Health Co. Inc. (BHC) Tops Q4 EPS by 12c; offers guidance
-
1,230,996 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


